Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05033756 |
| Title | Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO (COMPRENDO) |
| Acronym | COMPRENDO |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Institut fuer Frauengesundheit |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Department of Gynecology, Tübingen University Hospital | Tübingen | Baden-Württemberg | 72076 | Germany | Details | |
| University Hospital Ulm | Ulm | Baden-Württemberg | 89075 | Germany | Details | |
| Department of Gynecology and Obstetrics, Erlangen University Hospital | Erlangen | Bavaria | 91054 | Germany | Details | |
| Marienhospital Bottrop | Bottrop | North Rhine Westphalia | 46236 | Germany | Details | |
| University Hospital Düsseldorf | Düsseldorf | North Rhine Westphalia | 40225 | Germany | Details | |
| Helios-Klinikum Berlin-Buch | Berlin | 13125 | Germany | Details |